Trial intelligence / Profile preview

Phase 3 single-arm study of simeprevir plus peginterferon alfa-2a and ribavirin in treatment-naive chronic genotype 1 or 4 hepatitis C

2012-004905-29Phase 3Completed

Sponsor

Janssen Pharmaceutical

Start

May 2013

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1